Concepedia

Kannan Ramachandren

KR

Statistics

Publications

3

Citations

610

H-Index

3

Active since

2004

Affiliations

Johnson & Johnson (United States)(Current)

Kannan Ramachandren is an author at Johnson & Johnson (United States) specializing in ligand binding, medicine, and oncology pharmacology.

Publications per year

2004–2006

3

Publications

3

Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells

Bruce Grasberger, Tianbao Lu, Carsten J. Schubert et al. · Journal of Medicinal Chemistry · 2005 · 427 citations · Full text

, , +14

1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2–p53 interaction: discovery and SAR

Daniel J. Parks, Louis V. LaFrance, Raul R. Calvo et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 167 citations

, , +11

Effect of construct design on MAPKAP kinase-2 activity, thermodynamic stability and ligand-binding affinity

Jukka Kervinen, Hongchang Ma, Shariff Bayoumy et al. · Archives of Biochemistry and Biophysics · 2006 · 16 citations

, , +17

1–3 of 3